Pamela Youde Nethersole Eastern Hospital, known as Eastern Hospital or Youde Hospital is a acute district general hospital in Chai Wan, Hong Kong. The hospital opened on 15 October 1993 with 1829 beds and staff of over 3000.

There are 1,829 beds in Pamela Youde Nethersole Eastern Hospital.

During the past decade, Pamela Youde Nethersole Eastern Hospital conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 15 clinical trials were completed, i.e. on average, 48.4% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 6 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pamela Youde Nethersole Eastern Hospital" #1 sponsor was "The University of Hong Kong" with 10 trials, followed by "Pamela Youde Nethersole Eastern Hospital" with 7 trials sponsored, "Radiation Therapy Oncology Group" with 6 trials sponsored, "Chinese University of Hong Kong" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pamela Youde Nethersole Eastern Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Pamela Youde Nethersole Eastern Hospital" with 5 trials as a collaborator, "United Christian Hospital" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Pamela Youde Nethersole Eastern Hospital" are "Breast Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Nasopharyngeal Neoplasms" (3 trials), "Prostate Cancer" (3 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Pamela Youde Nethersole Eastern Hospital" in a lesser frequency.

Most popular intervention types in "Pamela Youde Nethersole Eastern Hospital" are "Drug" (38 trials), "Procedure" (8 trials), "Radiation" (8 trials), "Other" (7 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (7 trials), "Bevacizumab" (4 trials), "Paclitaxel" (4 trials), "Placebo" (4 trials) and "5-fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Pamela Youde Nethersole Eastern Hospital" are 48 trials for "All" genders, 11 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Pamela Youde Nethersole Eastern Hospital". undefined are not yet recruiting, 12 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Pamela Youde Nethersole Eastern Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Pamela Youde Nethersole Eastern Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 17 trials that are defined as “Not Applicable".